HPA021679
antibody from Atlas Antibodies
Targeting: CHAF1B
CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA021679 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA021679, RRID:AB_1846621
- Product name
- Anti-CHAF1B
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human CHAF1B, Gene description: chromatin assembly factor 1, subunit B (p60), Alternative Gene Names: CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7, Validated applications: ICC, IHC, WB, Uniprot ID: Q13112, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis
Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization
CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC
Ilter D, Drapela S, Schild T, Ward N, Adhikari E, Low V, Asara J, Oskarsson T, Lau E, DeNicola G, McReynolds M, Gomes A
Redox Biology 2023;61
Redox Biology 2023;61
Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization
Gomes A, Ilter D, Low V, Rosenzweig A, Shen Z, Schild T, Rivas M, Er E, McNally D, Mutvei A, Han J, Ou Y, Cavaliere P, Mullarky E, Nagiec M, Shin S, Yoon S, Dephoure N, Massagué J, Melnick A, Cantley L, Tyler J, Blenis J
Cancer Cell 2019;36(4):402-417.e13
Cancer Cell 2019;36(4):402-417.e13
CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC
Morra F, Merolla F, Picardi I, Russo D, Ilardi G, Varricchio S, Liotti F, Pacelli R, Palazzo L, Mascolo M, Celetti A, Staibano S
Cancers 2019;11(10):1582
Cancers 2019;11(10):1582
No comments: Submit comment
No validations: Submit validation data